Teva to Donate Buprenorphine Naloxone Valued at About $23 Billion in Opioid-Related Settlement
22 October 2019 - 5:43AM
Dow Jones News
By Josh Beckerman
Teva Pharmaceutical Industries Ltd. (TEVA, TEVA.TV) has reached
a framework for a multistate settlement of opioid-related
litigation, which would include donation of buprenorphine naloxone
tablets with a value of about $23 billion (at wholesale acquisition
cost).
Teva would also provide a cash payment of up to $250 million
over 10 years.
Teva said an agreement in principle includes attorneys general
from North Carolina, Pennsylvania, Tennessee and Texas, as well as
certain defendants.
Attorneys said earlier Monday that Teva and three other
companies agreed to a settlement with two Ohio counties.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
October 21, 2019 14:28 ET (18:28 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Apr 2024 to May 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From May 2023 to May 2024
